KDM2B and hepatocellular carcinoma: Increased levels of KDM5A, KDM5B and FBXL10 have also been observed in hepatocellular carcinoma, gastric cancer, lung cancer, pancreatic ductal adenocarcinoma, bladder cancer, colorectal cancer and prostate cancer26,27.